Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rutgers University Study of the Genetics of Pulmonary Hypertension

NCT07217522 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT07217522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07217522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rutgers University Study of the Genetics of Pulmonary Hypertension
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Observational
Overall status
Recruiting
Start date
August 23, 2025
Completion date
December 31, 2027
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial and chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension, pulmonary arterial hypertension (pah) (who group 1 ph), pulmonary arterial hypertension associated with connective tissue disease, pulmonary arterial hypertension associated with connective tissue disease (disorder), pulmonary arterial hypertension associated with schistosomiasis (disorder), pulmonary arterial hypertension of congenital heart disease, pulmonary hypertension